Nuvaxovid COVID-19 vaccine gets green light

Nuvaxovid, manufactured by the American biotech company Novavax, is suitable for people over 18 years of age, with a delay between doses of three weeks.

The health authority said the Novaxovid vaccine could be used for people who have not had any shots, or are unable to receive the mRNA vaccine.

The Ministry of Health said that the first Nuvaxovid injections could start in February, and will receive 3.2 million doses for the first trimester.

The first vaccine deliveries will arrive at the end of January.

Source: IANS


Source link


News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button